Therefore, we aimed to test whether total sleep time, measured by actigraphy during 1 week, was related to CSF AD core biomarkers (Aβ42/40, phosphorylated-tau-181, and total-tau) in elderly individuals, considering possible confounders and effect modifiers. This evidence concerns the gene MAPT and Alzheimer disease.